GDP growth across the G20 major world economies accelerated in the third quarter of 2021, but half remain below pre-pandemic levels, finds the OECD.
Researchers at the Ragon Institute of MGH, MIT and Harvard have shown the impact of booster shots on immunity against the Omicron COVID-19 variant.
Four major drivers of development, including public heath, are on an upward trajectory. These improving global trends give reason for hope we go into 2022.
Robust and reliable vaccine capacity in Africa is a global public good, deserving of global support. The fourth wave of COVID-19 echoes the need for support.
In order to achieve COVID-19 vaccine equity, businesses need to offer logistical expertise and infrastructure to deliver COVID-19 vaccines. Leveraging brand trust to combat disinformation...
A vaccine has never been developed, tried, tested and manufactured faster than the COVID-19 vaccines have, with a record-breaking manufacturing scale-up.
The EU has cleared Pfizer’s COVID pill for use to prevent hospitalization and death. It’s just one of many COVID-19 pills in development.
Access to and uptake of COVID-19 vaccines has been heterogeneous and uneven, with more advanced economies having received a larger share of vaccinations.
So far, Omicron symptoms generally appear to be mild, but there are gaps in our knowledge about its impact on the world in general, the elderly and the unvaccinated.
The COVID-19 omicron variant's ability to evade existing immunity is significantly depleted when people get boosted shots as a third coronavirus vaccine dose.
Research is underway across the world to understand the impact of Omicron on current vaccine effectiveness.
Around eight out of 10 workers worldwide support COVID-19 vaccine mandates for workplaces - and most believe the pandemic will eventually come to an end.
COVID-19 vaccines work well, but how can we make the best use of them? Getting first doses to people in all countries has to become the immediate priority.
A study shows people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech COVID-19 shots followed by Moderna nine weeks later.
Tick-borne diseases, including Lyme disease, are rising in North America, with almost 40,000 annual reported cases annually. New vaccination efforts could stem them.